[ Price : $8.95]
Tvardi Therapeutics says its experimental drug TTI-101 failed to show benefit in a Phase 2 clinical trial for idiopathic pulmonary...[ Price : $8.95]
Regeneron says new clinical data show its investigational gene therapy DB-OTO has restored meaningful hearing in nearly all childr...[ Price : $8.95]
FDA extends by three months its review of a Denali Therapeutics BLA for tividenofusp alfa, a potential treatment for Hunter syndro...[ Price : $8.95]
FDA approves an expanded indication for Medtronics Endurant II/IIs Stent Graft System, allowing its use in abdominal aortic aneury...[ Price : $8.95]
FDA grants BeOne Medicines a breakthrough therapy designation for sonrotoclax and its use in treating adults with relapsed or refr...[ Price : $8.95]
FDA assigns an Official Action Indicated classification to a recent inspection of a Novo Nordisk manufacturing facility in Bloomin...[ Price : $8.95]
FDA approves Celltrions Eydenzelt (aflibercept-boav), a biosimilar referencing Regeneron and Bayers blockbuster Eylea for treating...